Canada markets closed

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0667+0.0017 (+2.62%)
At close: 03:59PM EST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
13,560
16,837
8,244
446
0
Cost of Revenue
5,942
4,415
4,055
468
-
Gross Profit
7,618
12,422
4,189
-22
-
Operating Expenses
Research Development
3,246
25,032
33,129
17,050
22,230
Selling General and Administrative
30,891
71,514
137,861
86,552
30,512
Total Operating Expenses
34,137
96,546
170,990
103,602
52,742
Operating Income or Loss
-26,519
-84,124
-166,801
-103,624
-52,742
Total Other Income/Expenses Net
73,243
7,385
-38,389
-38,850
-27,745
Income Before Tax
46,782
-76,654
-205,175
-142,305
-80,029
Income Tax Expense
25
44
17
4
4
Income from Continuing Operations
46,757
-76,698
-205,192
-142,309
-80,033
Net Income
46,757
-76,698
-205,192
-142,309
-80,033
Net Income available to common shareholders
43,614
-78,014
-206,239
-142,309
-80,033
Basic EPS
-4.37
-167.50
-2.95k
-3.97k
-3.73k
Diluted EPS
-4.37
-167.50
-2.95k
-3.97k
-3.73k
Basic Average Shares
827.941
465.984
69.818
35.817
21.455
Diluted Average Shares
827.941
465.984
69.818
35.817
21.455